MondegarAI
Sio Capital Management, LLC

Q3 2024 · 13F-HR

Sio Capital Management, LLCholdings as filed

Filed 2024-11-14 · accession 0001214659-24-019074

$252.2M
Reported value
39
Positions
2024-09-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
504922105LHLABCORP HOLDINGS INC$38.7M15.4%173,293CommonSOLE
46120E602ISRGINTUITIVE SURGICAL INC$29.0M11.5%59,000PUTSOLE
881624209TEVATEVA PHARMACEUTICAL INDUSTRIES LTD$24.3M9.64%1,349,274CommonSOLE
577933104MMSMAXIMUS INC$14.5M5.73%155,142CommonSOLE
98956P102ZBHZIMMER BIOMET HOLDINGS INC$13.8M5.46%127,511CommonSOLE
92243A200VXRTVAXART INC$11.6M4.58%13,608,244CommonSOLE
49177J102KVUEKENVUE INC$11.0M4.35%474,741CommonSOLE
879369106TFXTELEFLEX INCORPORATED$9.7M3.85%39,272CommonSOLE
90240B106TYRATYRA BIOSCIENCES INC$9.4M3.74%400,870CommonSOLE
254604101IRONDISC MEDICINE INC$9.2M3.66%187,941CommonSOLE
125523100CITHE CIGNA GROUP$9.2M3.64%26,503CommonSOLE
03589W102ANNXANNEXON INC$8.5M3.36%1,433,155CommonSOLE
09075X108BIODESIX INC$7.7M3.06%4,338,514CommonSOLE
75943R102RLAYRELAY THERAPEUTICS INC$6.7M2.66%945,839CommonSOLE
29479A108ERASERASCA INC$6.1M2.40%2,219,186CommonSOLE
20451W101CMPSCOMPASS PATHWAYS PLC$5.8M2.28%914,639CommonSOLE
04635X102CATBUSDASTRIA THERAPEUTICS INC$5.6M2.20%504,887CommonSOLE
69353Y103PMVPPMV PHARMACEUTICALS INC$4.8M1.90%3,214,239CommonSOLE
92332V107VTYXUSDVENTYX BIOSCIENCES INC$4.3M1.70%1,971,948CommonSOLE
45166A102IDYAIDEAYA BIOSCIENCES INC$3.9M1.55%123,000CommonSOLE
228903100AORTARTIVION INC$3.2M1.28%121,178CommonSOLE
14179K101CRGXCARGO THERAPEUTICS INC$3.2M1.27%173,860CommonSOLE
21077P108CNTXCONTEXT THERAPEUTICS INC$2.6M1.03%1,328,352CommonSOLE
29251M106ENTAENANTA PHARMACEUTICALS INC$1.8M0.73%177,004CommonSOLE
67080N101NUVBNUVATION BIO INC$1.5M0.61%668,115CommonSOLE
344174107FHTXFOGHORN THERAPEUTICS INC.$1.1M0.45%121,672CommonSOLE
98420X103ASNSUSDX4 PHARMACEUTICALS INC$872,4380.35%1,303,508CommonSOLE
03836J201APREAPREA THERAPEUTICS INC$760,6580.30%276,603CommonSOLE
05338F306AVTXAVALO THERAPEUTICS INC$678,8510.27%71,458CommonSOLE
75382E109RAPT THERAPEUTICS INC$633,1500.25%315,000CommonSOLE
10170A100BOLDBOUNDLESS BIO INC$562,3410.22%162,058CommonSOLE
B6S7WD106NYXHNYXOAH SA$485,5120.19%50,839CommonSOLE
92337C203VSTMVERASTEM INC$398,9020.16%133,412CommonSOLE
60785L207MODULAR MED INC$271,7370.11%120,772CommonSOLE
65343E108NXTCEURNEXTCURE INC$178,1000.07%130,000CommonSOLE
44486Q111HUMAWHUMACYTE INC$88,9960.04%49,998CommonSOLE
880881107430TERNS PHARMACEUTICALS INC$83,4000.03%10,000CommonSOLE
77313F114RCKTWROCKET PHARMACEUTICALS INC$28,8600.01%400,000CommonSOLE
14171W111CAREMAX INC$1080.00%12,808CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.